Patel Pankti S, Rana Devang A, Suthar Jalpa V, Malhotra Supriya D, Patel Varsha J
Department of Pharmacology, Charotar University of Science and Technology, Changa, Gujarat, India.
Department of Pharmacology, Smt. NHL Municipal Medical College, Ahmedabad, Gujarat, India.
J Basic Clin Pharm. 2014 Mar;5(2):44-8. doi: 10.4103/0976-0105.134983.
To evaluate prevalence, types, and severity of potential adverse drug-drug interaction in medicine out-patient department.
A single-point, prospective, and observational study was carried out in medicine OPD. Study began after obtaining approval Institutional Ethics Committee. Data were collected and potential drug-drug interactions (pDDIs) were identified using medscape drug interaction checker and were analyzed.
A total of 350 prescriptions with mean age 52.45 ± 14.49 years were collected over a period of 5 months. A total of 2066 pDDIs were recorded with mean of 5.90 ± 6.0. The prevalence of pDDI was 83.42%. Aspirin was most frequently prescribed drug in 185 (10.15%) out of total of 1821 drugs It was also the most frequent drug implicated in pDDI i.e. in 48.16%. The most common pDDI identified was metoprolol with aspirin in 126 (6.09%). Mechanism of interactions was pharmacokinetic in 553 (26.76%), pharmacodynamic in 1424 (68.92%) and 89 (4.30%) having an unknown mechanism. Out of all interactions, 76 (3.67%) were serious, 1516 (73.37%) significant, and 474 (22.94%) were minor interaction. Age of the patients (r = 0.327, P = 0.0001) and number of drugs prescribed (r = 0.714, P = 0.0001) are significantly correlated with drug interactions.
Aspirin being the most common drug interacting. The use of electronic decision support tools, continuing education and vigilance on the part of prescribers toward drug selection may decrease the problem of pDDIs.
评估门诊潜在药物相互作用的发生率、类型及严重程度。
在门诊内科开展单点、前瞻性观察性研究。经机构伦理委员会批准后开始研究。收集数据并使用Medscape药物相互作用检查器识别潜在药物相互作用(pDDIs)并进行分析。
在5个月的时间里共收集了350份处方,患者平均年龄为52.45±14.49岁。共记录到2066次pDDIs,平均为5.90±6.0。pDDI的发生率为83.42%。阿司匹林是1821种药物中最常被处方的药物,在185例(10.15%)中出现。它也是pDDI中最常涉及的药物,即48.16%。最常见的pDDI是美托洛尔与阿司匹林,共126例(6.09%)。相互作用机制中,药代动力学占553例(26.76%),药效学占1424例(68.92%),89例(4.30%)机制不明。在所有相互作用中,76例(3.67%)为严重相互作用,1516例(73.37%)为显著相互作用,474例(22.94%)为轻微相互作用。患者年龄(r = 0.327,P = 0.0001)和处方药物数量(r = 0.714,P = 0.0001)与药物相互作用显著相关。
阿司匹林是最常见的相互作用药物。使用电子决策支持工具、开展继续教育以及开处方者在药物选择方面保持警惕,可能会减少pDDIs问题。